| Literature DB >> 21995607 |
Jacob J Michaelson1, Saskia Trump, Susanne Rudzok, Carolin Gräbsch, Danielle J Madureira, Franziska Dautel, Juliane Mai, Sabine Attinger, Kristin Schirmer, Martin von Bergen, Irina Lehmann, Andreas Beyer.
Abstract
BACKGROUND: Small molecule ligands often have multiple effects on the transcriptional program of a cell: they trigger a receptor specific response and additional, indirect responses ("side effects"). Distinguishing those responses is important for understanding side effects of drugs and for elucidating molecular mechanisms of toxic chemicals.Entities:
Mesh:
Substances:
Year: 2011 PMID: 21995607 PMCID: PMC3215681 DOI: 10.1186/1471-2164-12-502
Source DB: PubMed Journal: BMC Genomics ISSN: 1471-2164 Impact factor: 3.969
Figure 1Exposing cells to B[a]P provokes a complex intracellular response. Exposing cells to B[a]P provokes a complex intracellular response. In Ahr expressing cells (+Ahr) B[a]P is metabolized, causing side effects due to its active metabolite BPDE. Since this metabolism is dependent on P450 enzymes that are activated by Ahr, side effects caused by B[a]P metabolism should only be detectable in +Ahr, while effects of direct exposure to BPDE should be independent of Ahr (A). Primary responders to Ahr are activated by B[a]P exposure only in +Ahr (B); these include other TFs. These TFs can in turn activate their target genes with a time lag compared to the primary Ahr response (C).
Figure 2Framework for predicting Ahr targets. Framework for predicting Ahr primary responders and side effects using gene expression time course data.
List of predicted primary targets of Ahr.
| MGI ID | cluster votes | target votes | train/test | MGI ID | cluster votes | target votes | train/test |
|---|---|---|---|---|---|---|---|
| Hspa4l | 1.00 | 0.98 | test | Ccng2 | 0.98 | 0.9 | test |
| 2410066E13Rik | 1.00 | 0.98 | test | Fam198b | 0.98 | 0.9 | test |
| Arl6ip5 | 1.00 | 0.98 | test | Ddit4 | 0.98 | 0.9 | test |
| Plscr2 | 1.00 | 0.98 | test | Ubl3 | 0.98 | 0.87 | test |
| Mpp2 | 1.00 | 0.98 | training | Nqo1 | 0.98 | 0.87 | test |
| Tiparp | 1.00 | 0.98 | training | Trp53inp1 | 0.98 | 0.87 | test |
| Sdpr | 1.00 | 0.98 | test | Cyp1a1 | 0.98 | 0.86 | test |
| Ndrg1 | 1.00 | 0.97 | test | Abca6 | 0.98 | 0.86 | test |
| Nrn1 | 1.00 | 0.97 | test | Hmox1 | 0.98 | 0.83 | test |
| Cyp2s1 | 1.00 | 0.97 | test | Aldh4a1 | 0.98 | 0.81 | test |
| Tnfaip2 | 1.00 | 0.97 | test | Npffr1 | 0.97 | 0.91 | test |
| Cpox | 1.00 | 0.97 | training | 0.97 | 0.89 | test | |
| Osbpl2 | 1.00 | 0.97 | test | 0.97 | 0.87 | test | |
| Rbks | 1.00 | 0.96 | test | Gm10122 | 0.97 | 0.87 | test |
| 1.00 | 0.96 | training | Snx30 | 0.96 | 0.96 | training | |
| Tbc1d16 | 1.00 | 0.95 | test | Cdkn1b | 0.96 | 0.92 | test |
| Arrdc3 | 1.00 | 0.95 | training | Slc26a2 | 0.96 | 0.88 | test |
| 1.00 | 0.95 | test | Plk2 | 0.96 | 0.85 | test | |
| 1.00 | 0.94 | test | 0.96 | 0.83 | test | ||
| Xdh | 1.00 | 0.94 | test | Zfp608 | 0.95 | 0.92 | training |
| Gramd3 | 1.00 | 0.94 | test | Nrg1 | 0.95 | 0.91 | test |
| Serpine1 | 1.00 | 0.93 | test | Abcd2 | 0.95 | 0.8 | test |
| Pfkfb3 | 0.99 | 0.98 | training | 0.94 | 0.94 | test | |
| Jub | 0.99 | 0.97 | test | Dusp1 | 0.94 | 0.92 | training |
| Ddx58 | 0.99 | 0.97 | training | Tnfaip8 | 0.94 | 0.88 | test |
| Zfp418 | 0.99 | 0.95 | test | 9330175E14Rik | 0.94 | 0.82 | test |
| Sgk1 | 0.99 | 0.94 | test | Lrrc30 | 0.93 | 0.89 | test |
| 0.99 | 0.93 | test | Eda2r | 0.93 | 0.85 | test | |
| Cdkn1a | 0.99 | 0.92 | test | Bmf | 0.92 | 0.93 | test |
| Abcc4 | 0.99 | 0.91 | test | Rnf39 | 0.91 | 0.92 | training |
| Slc6a9 | 0.99 | 0.91 | test | St6gal1 | 0.9 | 0.94 | training |
| Adh7 | 0.99 | 0.90 | test | Zfp36l1 | 0.89 | 0.83 | test |
| Usp18 | 0.99 | 0.90 | test | 0.86 | 0.91 | training | |
| Npc1 | 0.99 | 0.88 | test | Irs2 | 0.86 | 0.91 | test |
| Casp3 | 0.99 | 0.87 | test | 0.84 | 0.86 | training | |
| Aldh3a1 | 0.99 | 0.86 | test | 0.78 | 0.86 | test | |
| Slc35d1 | 0.99 | 0.85 | test | 0.76 | 0.91 | training | |
| Cyp1b1 | 0.98 | 0.97 | test | Cib2 | 0.71 | 0.84 | test |
| Intu | 0.98 | 0.95 | training | S1pr1 | 0.7 | 0.89 | training |
| Pitpnc1 | 0.98 | 0.95 | training | Traf5 | 0.59 | 0.89 | training |
| Sesn2 | 0.98 | 0.92 | training |
List of predicted primary targets of Ahr transcriptional regulation. Confidence scores of both membership in cluster 3 (cluster votes) and as a primary Ahr target (target votes) are given. Known transcriptional regulators (i.e. annotated with relevant GO terms) are bolded. Additionally, assignment to either the training or test set is indicated for each gene.
Figure 3Clustering with the RF proximity measure. PAM clustering was performed with a supervised, weighted distance measure, derived during the classification of Ahr primary responders and side effects. Three distinct programs were found, depicted here as clusters (1-3). Color saturation indicates the importance of the time points for the identity of the cluster. To further emphasize these important time points, this same information is shown again for each cluster (black to yellow scale). The classification of each gene is shown as the proportion of RF votes.
Figure 4Enrichment of each cluster for Ahr mutant-perturbed genes. Using data from previous Ahr mutant studies [7,19], we assessed whether each cluster was enriched (relative to the other clusters) for genes perturbed by an Ahr mutation. Only genes not used in the training of the classifier were used in the calculation of enrichment. Cluster 3 was highly enriched for perturbed genes, suggesting that it is enriched for Ahr targets.